Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial.
Natsuaki M, Morimoto T, Yamamoto E, Shiomi H, Furukawa Y, Abe M, Nakao K, Ishikawa T, Kawai K, Yunoki K, Shimizu S, Akao M, Miki S, Yamamoto M, Okada H, Hoshino K, Kadota K, Morino Y, Igarashi K, Tanabe K, Kozuma K, Kimura T. Natsuaki M, et al. Among authors: nakao k. Cardiovasc Interv Ther. 2016 Jul;31(3):196-209. doi: 10.1007/s12928-015-0366-9. Epub 2015 Oct 30. Cardiovasc Interv Ther. 2016. PMID: 26518420 Free PMC article. Clinical Trial.
Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
Abe M, Kimura T, Morimoto T, Taniguchi T, Yamanaka F, Nakao K, Yagi N, Kokubu N, Kasahara Y, Kataoka Y, Otsuka Y, Kawamura A, Miyazaki S, Nakao K, Horiuchi K, Ito A, Hoshizaki H, Kawaguchi R, Setoguchi M, Inada T, Kishi K, Sakamoto H, Morioka N, Imai M, Shiomi H, Nonogi H, Mitsudo K; j-Cypher Registry Investigators. Abe M, et al. Among authors: nakao k. Circulation. 2010 Jul 6;122(1):42-51. doi: 10.1161/CIRCULATIONAHA.109.905802. Epub 2010 Jun 21. Circulation. 2010. PMID: 20566954
Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
Ozasa N, Kimura T, Morimoto T, Hou H, Tamura T, Shizuta S, Nakagawa Y, Furukawa Y, Hayashi Y, Nakao K, Matsuzaki M, Nobuyoshi M, Mitsudo K; j-Cypher Registry Investigators. Ozasa N, et al. Among authors: nakao k. Am J Cardiol. 2010 Nov 1;106(9):1225-33. doi: 10.1016/j.amjcard.2010.06.048. Epub 2010 Sep 9. Am J Cardiol. 2010. PMID: 21029817
Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.
Tada T, Kimura T, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Nakashima H, Ito A, Siode N, Namura M, Inoue N, Nishikawa H, Nakao K, Mitsudo K; j-Cypher Registry Investigators. Tada T, et al. Among authors: nakao k. Am J Cardiol. 2011 Apr 15;107(8):1155-62. doi: 10.1016/j.amjcard.2010.12.013. Epub 2011 Feb 4. Am J Cardiol. 2011. PMID: 21296326 Free article.
Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry.
Kimura T, Morimoto T, Nakagawa Y, Kadota K, Nozaki Y, Tada T, Take S, Shirota K, Ito A, Nakashima H, Fujita H, Kawasaki T, Inada T, Nakao K, Miyazaki S, Doi O, Isshiki T, Nobuyoshi M, Mitsudo K. Kimura T, et al. Among authors: nakao k. Cardiovasc Interv Ther. 2012 Sep;27(3):181-8. doi: 10.1007/s12928-012-0109-0. Epub 2012 Jun 14. Cardiovasc Interv Ther. 2012. PMID: 22695921
Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease.
Sakamoto T, Ogawa H, Nakao K, Koide S, Yamamoto N, Shimomura H, Matsumura T, Oshima S, Kikuta K, Oka H, Kimura K, Matsui K; 4C (Canderstan for Prevention of Cardiovascular Events after CYPHER or TAXUS Coronary Stenting) investigators. Sakamoto T, et al. Among authors: nakao k. J Atheroscler Thromb. 2013;20(5):472-80. doi: 10.5551/jat.13870. Epub 2013 Mar 14. J Atheroscler Thromb. 2013. PMID: 23411616 Free article. Clinical Trial.
Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET).
Kozuma K, Kimura T, Kadota K, Suwa S, Kimura K, Iwabuchi M, Kawai K, Miyazawa A, Kawamura M, Nakao K, Asano R, Yamamoto T, Suzuki N, Aoki J, Kyono H, Nakazawa G, Tanabe K, Morino Y, Igarashi K. Kozuma K, et al. Among authors: nakao k. Cardiovasc Interv Ther. 2013 Oct;28(4):344-51. doi: 10.1007/s12928-013-0179-7. Epub 2013 Apr 23. Cardiovasc Interv Ther. 2013. PMID: 23608784 Clinical Trial.
Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K; j-Cypher Registry Investigators. Toyofuku M, et al. Among authors: nakao k. JACC Cardiovasc Interv. 2013 Jul;6(7):654-63. doi: 10.1016/j.jcin.2013.03.015. JACC Cardiovasc Interv. 2013. PMID: 23866178 Free article.
Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial.
Shiomi H, Kozuma K, Morimoto T, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Uematsu M, Tarutani Y, Fujii K, Simonton CA, Kimura T; RESET Investigators. Shiomi H, et al. Among authors: nakao k. Circ Cardiovasc Interv. 2014 Jun;7(3):343-54. doi: 10.1161/CIRCINTERVENTIONS.113.001322. Epub 2014 May 6. Circ Cardiovasc Interv. 2014. PMID: 24803436 Clinical Trial.
3,308 results